Agneta Heierson
Corporate Officer/Principal bij INFANT BACTERIAL THERAPEUTICS AB
Profiel
Agneta Heierson is currently the Vice President-Clinical Development at Infant Bacterial Therapeutics AB.
She previously worked as the Global VP-Research & Development Supply Chain at AstraZeneca AB.
Actieve functies van Agneta Heierson
| Bedrijven | Functie | Begin |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Corporate Officer/Principal | - |
Eerdere bekende functies van Agneta Heierson
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
